Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Be aware of local regulations regarding peptide possession and travel with any relevant documentation
Published preclinical work has described: Reduced de novo lipogenesis in adipocytes Reduced hepatic lipogenesis in diet-induced obesity models Improved adipose tissue metabolic markers Licensed Healthcare Practitioners 1,000+ physician-grade products, bulk-tier pricing, and direct shipping to your practice
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule selective inhibitor of nicotinamide N-methyltransferase (NNMT) developed at the University of Texas Medical Branch by Neelakantan and colleagues as part of a medicinal-chemistry program targeting NNMT for metabolic-disease research
The lack of blood supply to the heart may cause heart attacks and the lack of blood supply to the brain accelerates the development of dementia and may lead to strokes (3, 4)
The trial was registered at irct.ir website (IRCT20120718010333N5)
US$ 23.35
US$ 28.16
US$ 29.25
US$ 26.72
US$ 23.74
US$ 20.27
US$ 24.59
US$ 20.25
US$ 26.36
